GLP-1 Therapeutics Market Size, Share & Industry Analysis, By Drug Class (GLP-1 Receptor Agonists, Dual GIP/GLP-1 Receptor Agonists, Oral GLP-1 Therapies); By Indication (Type 2 Diabetes, Obesity & Weight Management, Cardiovascular Risk Reduction, Non-Alcoholic Steatohepatitis); By Route of Administration (Injectable and Oral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031